We want to see things from your perspective. We seek to collaborate with other biotechs, pharmaceuticals, universities, and organizations who want to combat disease from a new angle.
“We have an extraordinary team committed to our science and our patients.”
Nagesh Mahanthappa, PhD, MBA
Interim CEO
Asset Development
Janssen Pharmaceuticals
Collaborating in Patient Advocacy
Spinal Muscular Atrophy
SMA Foundation
CureSMA
SMA Europe